BACKGROUND: Genetic diagnosis of autosomal recessive polycystic kidney disease (ARPKD) is challenging due to the length and allelic heterogeneity of the PKHD1 gene. Mutations appear to be clustered at specific exons, depending on the geographic origin of the patient. We aimed to identify the PKHD1 exons most likely mutated in Spanish ARPKD patients. METHODS: Mutation analysis was performed in 50 ARPKD probands and nine ARPKD-suspicious patients by sequencing PKHD1 exons arranged by their reported mutation frequency. Haplotypes containing the most frequent mutations were analyzed. Other PKD genes (HNF1B, PKD1, PKD2) were sequenced in PKHD1-negative cases. RESULTS: Thirty-six different mutations (concentrated in 24 PKHD1 exons) were detected, giving a mutation detection rate of 86%. The screening of five exons (58, 32, 34, 36, 37) yielded a 54% chance of detecting one mutation; the screening of nine additional exons (3, 9, 39, 61, 5, 22, 26, 41, 57) increased the chance to 76%. The c.9689delA mutation was present in 17 (34%) patients, all of whom shared the same haplotype. Two HNF1B mutations and one PKD1 variant were detected in negative cases. CONCLUSIONS: Establishing a PKHD1 exon mutation profile in a specific population and starting the analysis with the most likely mutated exons might significantly enhance the efficacy of genetic testing in ARPKD. Analysis of other PKD genes might be considered, especially in suspicious cases.
BACKGROUND: Genetic diagnosis of autosomal recessive polycystic kidney disease (ARPKD) is challenging due to the length and allelic heterogeneity of the PKHD1 gene. Mutations appear to be clustered at specific exons, depending on the geographic origin of the patient. We aimed to identify the PKHD1 exons most likely mutated in Spanish ARPKDpatients. METHODS: Mutation analysis was performed in 50 ARPKD probands and nine ARPKD-suspicious patients by sequencing PKHD1 exons arranged by their reported mutation frequency. Haplotypes containing the most frequent mutations were analyzed. Other PKD genes (HNF1B, PKD1, PKD2) were sequenced in PKHD1-negative cases. RESULTS: Thirty-six different mutations (concentrated in 24 PKHD1 exons) were detected, giving a mutation detection rate of 86%. The screening of five exons (58, 32, 34, 36, 37) yielded a 54% chance of detecting one mutation; the screening of nine additional exons (3, 9, 39, 61, 5, 22, 26, 41, 57) increased the chance to 76%. The c.9689delA mutation was present in 17 (34%) patients, all of whom shared the same haplotype. Two HNF1B mutations and one PKD1 variant were detected in negative cases. CONCLUSIONS: Establishing a PKHD1 exon mutation profile in a specific population and starting the analysis with the most likely mutated exons might significantly enhance the efficacy of genetic testing in ARPKD. Analysis of other PKD genes might be considered, especially in suspicious cases.
Authors: Sandro Rossetti; Katharina Hopp; Robert A Sikkink; Jamie L Sundsbak; Yean Kit Lee; Vickie Kubly; Bruce W Eckloff; Christopher J Ward; Christopher G Winearls; Vicente E Torres; Peter C Harris Journal: J Am Soc Nephrol Date: 2012-03-01 Impact factor: 10.121
Authors: A M Sharp; L M Messiaen; G Page; C Antignac; M-C Gubler; L F Onuchic; S Somlo; G G Germino; L M Guay-Woodford Journal: J Med Genet Date: 2005-04 Impact factor: 6.318
Authors: Luiz F Onuchic; Laszlo Furu; Yasuyuki Nagasawa; Xiaoying Hou; Thomas Eggermann; Zhiyong Ren; Carsten Bergmann; Jan Senderek; Ernie Esquivel; Raoul Zeltner; Sabine Rudnik-Schöneborn; Michael Mrug; William Sweeney; Ellis D Avner; Klaus Zerres; Lisa M Guay-Woodford; Stefan Somlo; Gregory G Germino Journal: Am J Hum Genet Date: 2002-03-15 Impact factor: 11.025
Authors: K Zerres; G Mücher; L Bachner; G Deschennes; T Eggermann; H Kääriäinen; M Knapp; T Lennert; J Misselwitz; K E von Mühlendahl Journal: Nat Genet Date: 1994-07 Impact factor: 38.330
Authors: Sandro Rossetti; Mark B Consugar; Arlene B Chapman; Vicente E Torres; Lisa M Guay-Woodford; Jared J Grantham; William M Bennett; Catherine M Meyers; Denise L Walker; Kyongtae Bae; Qin Jean Zhang; Paul A Thompson; J Philip Miller; Peter C Harris Journal: J Am Soc Nephrol Date: 2007-06-20 Impact factor: 10.121
Authors: Jana Reiterová; Jitka Štekrová; Miroslav Merta; Jaroslav Kotlas; Veronika Elišáková; Petr Lněnička; Marie Korabečná; Milada Kohoutová; Vladimír Tesař Journal: BMC Nephrol Date: 2013-03-15 Impact factor: 2.388
Authors: Tamás Szabó; Petronella Orosz; Eszter Balogh; Eszter Jávorszky; István Máttyus; Csaba Bereczki; Zoltán Maróti; Tibor Kalmár; Attila J Szabó; George Reusz; Ildikó Várkonyi; Erzsébet Marián; Éva Gombos; Orsolya Orosz; László Madar; György Balla; János Kappelmayer; Kálmán Tory; István Balogh Journal: Pediatr Nephrol Date: 2018-06-28 Impact factor: 3.714
Authors: Thomas Götze; Holger Blessing; Christian Grillhösl; Patrick Gerner; André Hoerning Journal: Front Pediatr Date: 2015-06-17 Impact factor: 3.418
Authors: Brian D Friend; Kami Wolfe Schneider; Timothy Garrington; Laurel Truscott; Julian A Martinez-Agosto; Robert S Venick; Eileen Tsai Chambers; Patricia Weng; Douglas G Farmer; Vivian Y Chang; Noah Federman Journal: Mol Genet Genomic Med Date: 2019-06-14 Impact factor: 2.183